News
Find out how to take Insulin Glulisine(drug) and its dose. Describes the best time to take the drug and precautions if any that should be followed.
Patients and health care professionals can expect a shortage of insulin glulisine prefilled pens, including Apidra Optiset and Apidra SoloStar, and reusable cartridges, including Apidra ClikStar ...
The 24-week study, titled, “Adjust to Target in Type 2 Diabetes: Comparison of a Single Algorithm to Carbohydrate Counting for Adjustment of Mealtime Insulin Glulisine,” compared two ...
Review the side-effects of Insulin Glulisine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.
Hospitalized patients with type 2 diabetes, especially those who have a prolonged length of stay, experienced better glycemic control with glulisine as compared with regular insulin, according to ...
Apidra SoloSTAR (insulin glulisine [rDNA origin] injection, from sanofi-aventis), a prefilled disposable pen containing Apidra, is now available.
Such medications as Fiasp (insulin aspart), Humalog (insulin lispro), Apidra (insulin glulisine) belong to this category. Short-acting insulin This type starts improving blood glucose levels about ...
Insulin aspart (Novo Nordisk’s Novolog) and insulin glulisine (Sanofi’s Apidra) quickly followed. With rapid-acting insulin analogs, onset occurs 10 to 20 minutes after injection, ...
Types of insulin include rapid-, regular-, intermediate-, and long-acting, based on how long they take to start working. You may take a combination of these when managing type 2 diabetes.
Mylan Pharms. Inc. v. Sanofi-Aventis Deutschland Gmbh, IPR2018-01670 (PTAB) Sept. 10, 2018 N/A Lantus® SoloStar® (insulin glargine recombinant for injection), Apidra® SoloStar® (insulin ...
The FDA has approved Apidra SoloSTAR (insulin glulisine [rDNA origin] injection, from sanofi-aventis), a prefilled disposable pen containing Apidra.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results